VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
3.155
+0.025 (0.80%)
At close: Nov 7, 2024, 4:00 PM
3.110
-0.045 (-1.43%)
After-hours: Nov 7, 2024, 6:01 PM EST

VYNE Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for VYNE Therapeutics stock has a target of 5.75, which predicts an increase of 82.25% from the current stock price of 3.16.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.75 $5.75 $5.75 $5.75
Change +82.25% +82.25% +82.25% +82.25%
* Price targets were last updated on Sep 12, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for VYNE is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong Buy Reiterates $5.75 +82.25% Sep 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong Buy Reiterates $5.75 +82.25% Aug 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong Buy Reiterates $5.75 +82.25% Jun 14, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong Buy Reiterates $5.75 +82.25% Jun 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5.75
Strong Buy Reiterates $5.75 +82.25% May 9, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
561.00K
from 424.00K
Increased by 32.31%
Revenue Next Year
n/a
from 561.00K
EPS This Year
-0.62
from -2.78
EPS Next Year
-0.89
from -0.62
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
443.00K20.99M931.00K477.00K424.00K561.00K--
Revenue Growth
-87.68%4,638.83%-95.57%-48.76%-11.11%32.31%--
EPS
-201.91-141.90-25.65-7.28-2.78-0.62-0.89-0.79
EPS Growth
--------
Forward PE
--------
No. Analysts -----544
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 630,000 n/a n/a
Avg 561,000 n/a n/a
Low 490,000 n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
48.6%
- -
Avg
32.3%
- -
Low
15.6%
- -

EPS Forecast

EPS 20242025202620272028
High -0.10 -0.91 -0.81
Avg -0.62 -0.89 -0.79
Low -0.89 -0.85 -0.75

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.